NCT00299299|Unknown
Loading search results
Sponsor study identifier
observational
10
1 country
1
Study Start
June 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
Not reported
Date not reportedThis study tests the feasibility and reproducibility of patient-specific motion models. These will be used for quantification of safe margin reduction. Patient-specific motion models will be built by post-processing 4D MRI data with non-rigid registration. By comparing these models between visits, model reproducibility will be assessed, and the methodology refined.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 3, 2006
Actual (reported)March 6, 2006
Actual (reported)June 2006
Date type not reportedThis date has not been verified as actual or estimated.
10 RMH patients aged over 18 years with single or multiple hepatic metastases secondary to colorectal cancer. Metastases at other sites will not be an exclusion criterion. WHO performance status 0, 1 or 2.
Royal Marsden Hospital
Chelsea, United Kingdom
Dr Diana Tait
Royal Marsden HNHS Foundation Trust
First Submitted
March 3, 2006
First Posted
March 6, 2006
Study Start
June 2006
Date type not reportedThis date has not been verified as actual or estimated.
Last Updated
January 12, 2010
Record last verified: 2010-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Contact the study team to confirm eligibility.